Neutrophilic panniculitis following azacitidine treatment for myelodysplastic syndromes.
作者信息
Kim In-Ho, Youn Jae-Ho, Shin Seung-Hwan, Yahng Seung-Ah, Lee Sung-Eun, Kwon Jae-Cheol, Lee Dong-Gun, Park Kyung-Shin, Choi Moon-Hyung, Jung Seung-Eun, Kim Yoo-Jin
出版信息
Leuk Res. 2012 Jul;36(7):e146-8. doi: 10.1016/j.leukres.2012.03.007. Epub 2012 Apr 5.
Abstract
摘要
相似文献
1
Neutrophilic panniculitis following azacitidine treatment for myelodysplastic syndromes.阿扎胞苷治疗骨髓增生异常综合征后发生的嗜中性脂膜炎。
Leuk Res. 2012 Jul;36(7):e146-8. doi: 10.1016/j.leukres.2012.03.007. Epub 2012 Apr 5.
2
Neutrophilic panniculitis associated with myelodysplastic syndrome with abnormal nuclear forms.与具有异常核形态的骨髓增生异常综合征相关的嗜中性脂膜炎
J Cutan Pathol. 2009 Sep;36(9):1024-6. doi: 10.1111/j.1600-0560.2009.01196.x.
3
Is there an association between 5-azacitidine and ototoxicity?5-氮杂胞苷与耳毒性之间是否存在关联？
J Clin Pharmacol. 2010 Sep;50(9):1056-7. doi: 10.1177/0091270009360536. Epub 2010 Mar 16.
4
Strongly suspicious hemolysis caused by azacitidine in a myelodysplastic syndrome patient.一名骨髓增生异常综合征患者中由阿扎胞苷引起的高度可疑溶血。
Geriatr Gerontol Int. 2014 Oct;14(4):1006-7. doi: 10.1111/ggi.12226.
5
Real-life experience with azacitidine in myelodysplastic syndromes according to IPSS cytogenetic profile.根据国际预后评分系统（IPSS）细胞遗传学特征，阿扎胞苷治疗骨髓增生异常综合征的真实生活经验。
Am J Hematol. 2014 May;89(5):565. doi: 10.1002/ajh.23677. Epub 2014 Feb 28.
6
Leukemia cutis in myelodysplastic syndrome and chronic myelomonocytic leukemia patients treated with adjusted dose 5-azacitidine.接受调整剂量5-氮杂胞苷治疗的骨髓增生异常综合征和慢性粒单核细胞白血病患者的皮肤白血病
Eur J Dermatol. 2015 Nov-Dec;25(6):622-3. doi: 10.1684/ejd.2015.2661.
7
Decitabine.地西他滨
Nat Rev Drug Discov. 2006 Nov;5(11):891-2. doi: 10.1038/nrd2180.
8
Azacitidine and the beginnings of therapeutic epigenetic modulation.阿扎胞苷与治疗性表观遗传调控的开端
Expert Opin Pharmacother. 2008 Aug;9(11):1981-6. doi: 10.1517/14656566.9.11.1981.
9
Pyoderma gangrenosum secondary to azacitidine in myelodysplastic syndrome.骨髓增生异常综合征中阿扎胞苷继发的坏疽性脓皮病。
Br J Haematol. 2015 May;169(4):461. doi: 10.1111/bjh.13341. Epub 2015 Mar 12.
10
Infectious complications in patients with myelodysplastic syndromes: A review of the literature with emphasis on patients treated with 5-azacitidine.骨髓增生异常综合征患者的感染并发症：文献综述，重点关注接受5-氮杂胞苷治疗的患者。
Eur J Haematol. 2017 Aug;99(2):112-118. doi: 10.1111/ejh.12883. Epub 2017 Apr 20.
引用本文的文献
1
Recurrent Subcutaneous Sweet's Disease in a Myelofibrosis Patient Treated with Ruxolitinib before Allogeneic Stem Cell Transplantation.异基因干细胞移植前接受鲁索替尼治疗的骨髓纤维化患者复发性皮下Sweet病
Intern Med. 2017 Sep 15;56(18):2481-2485. doi: 10.2169/internalmedicine.8491-16. Epub 2017 Aug 21.
2
Use of azacitidine for myelodysplastic syndromes: controversial issues and practical recommendations.阿扎胞苷在骨髓增生异常综合征中的应用：争议问题与实用建议。
Blood Res. 2013 Jun;48(2):87-98. doi: 10.5045/br.2013.48.2.87. Epub 2013 Jun 25.
Zotero 插件